Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction

March 31, 2023 updated by: Emily Miller, Northwestern University

A Randomized Clinical Trial of Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction

Amniotomy (breaking the bag of water) is commonly used in the induction of labor. However, the timing is highly variable. The purpose of this study is to determine if first time mothers undergoing induction of labor with a Foley catheter experience a decrease in their labor time when undergoing early amniotomy (breaking the bag of water within 1 hour of Foley catheter removal) than when undergoing delayed amniotomy (breaking the bag of water at least 4 hours after Foley catheter removal). Other aims include the relationship between timing of amniotomy and cesarean section, postpartum hemorrhage, intrauterine infection, neonatal Apgar score <7 at 5 minutes, neonatal need for intensive care.

The investigators hypothesize that induction of labor with Foley catheters followed by early amniotomy will result in a decreased duration of labor compared to those who undergo delayed amniotomy.

Study Overview

Detailed Description

This randomized clinical trial of consenting nulliparous women undergoing induction of labor with a Foley catheter seeks to determine whether use of early amniotomy (defined as amniotomy within 1 hour of Foley catheter removal) improves obstetrical outcomes when compared with delayed amniotomy (defined as amniotomy at least 4 hours following Foley catheter removal).

This project will include 110 women recruited from the obstetrical service at Prentice Women's Hospital. Women will be included if they are at least 37 weeks gestation, have a singleton pregnancy, have intact membranes and are undergoing an induction of labor using a Foley catheter. Following removal of Foley catheter, women will be assessed for safety of amniotomy and if appropriate, randomized to either early amniotomy or delayed amniotomy.

Women will be randomized with equal probability to the intervention group using block randomization stratified by use of Foley catheter alone or Foley catheter-misoprostol use.

Women in the early amniotomy group will undergo amniotomy within 1 hour of Foley catheter removal. Women in the delayed amniotomy group will undergo amniotomy at least 4 hours following Foley removal. The remainder of labor management will be at the discretion of each woman's obstetric provider.

Prior to discharge from the hospital, baseline demographic and clinical data will be obtained via chart review

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Prentice Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Able to provide informed consent
  • English speaking
  • Women age 18 years old or greater
  • Nulliparous
  • Pregnant with a singleton gestation that is greater than or equal to 37 weeks
  • Undergoing induction of labor with Foley catheter

Exclusion Criteria:

  • Women not meeting above criteria
  • Fetus in non-cephalic position
  • Intrauterine fetal demise
  • Fetus with major anomalies
  • HIV, hepatitis B or C infection
  • Planned use of oxytocin during the Foley catheter ripening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Amniotomy
Patients undergoing induction of labor with foley catheter, with or without concurrent use of misoprostol, will undergo amniotomy within 1 hour of Foley catheter removal.
Artificially rupturing membranes
Foley catheter device is commonly used for cervical ripening during labor induction. It is used independently or in combination with pharmacologic augmentation. It is inserted in the cervix and the balloon is then inflated with 60 cc of saline. It is removed when either 1. it falls out under gentile traction during labor checks or 2. it is de-inflated at 12 hours after placement. If at the time of de-inflation at 12 hours, the desired affect has not been achieved, the provider may choose to place another foley balloon or use an alternative method of induction (misoprostol). This is an eligibility criteria and only patients who are undergoing induction with a Foley Catheter will be approached for enrollment.
Misoprostol is a medication that is commonly used for cervical ripening during labor induction. It is commonly used independently or in combination with mechanical methods, such as a foley catheter. The commonly used dose during term labor induction is 25 mcg. Use of this medication will be decided by the provider.
Active Comparator: Delayed Amniotomy
Patients undergoing induction of labor with foley catheter, with or without concurrent use of misoprostol, will undergo amniotomy no sooner than 4 hours following removal of Foley catheter.
Artificially rupturing membranes
Foley catheter device is commonly used for cervical ripening during labor induction. It is used independently or in combination with pharmacologic augmentation. It is inserted in the cervix and the balloon is then inflated with 60 cc of saline. It is removed when either 1. it falls out under gentile traction during labor checks or 2. it is de-inflated at 12 hours after placement. If at the time of de-inflation at 12 hours, the desired affect has not been achieved, the provider may choose to place another foley balloon or use an alternative method of induction (misoprostol). This is an eligibility criteria and only patients who are undergoing induction with a Foley Catheter will be approached for enrollment.
Misoprostol is a medication that is commonly used for cervical ripening during labor induction. It is commonly used independently or in combination with mechanical methods, such as a foley catheter. The commonly used dose during term labor induction is 25 mcg. Use of this medication will be decided by the provider.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time interval from Foley catheter removal to delivery
Time Frame: Number of hours from removal of Foley catheter to delivery of neonate; up to 72 hours.
Hours
Number of hours from removal of Foley catheter to delivery of neonate; up to 72 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean delivery
Time Frame: At time of delivery
binary; yes/no
At time of delivery
Chorioamnionitis
Time Frame: From time of admission to Labor and Delivery unit to delivery of neonate; up to 72 hours
Maternal Temperature of >/= 39 degrees Celsius or >/= 38 degrees Celsius on two occasions greater than 30 minutes apart and at least one of the following: Fetal tachycardia (defined as sustained (>10 min) fetal heart rate >160), White Bood Cell Count >15, purulent fluid from cervical os, or receipt of antibiotics and diagnosis written in the chart
From time of admission to Labor and Delivery unit to delivery of neonate; up to 72 hours
Postpartum Fever
Time Frame: From time of delivery to time of hospital discharge; up to 6 weeks
Temperature >/= 38 degrees celsius on 2 separate occasions greater than 6 hours apart
From time of delivery to time of hospital discharge; up to 6 weeks
Wound infection
Time Frame: From time of delivery to time of hospital discharge; up to 6 weeks
Cellulitis or erythema and induration around the incision and purulent discharge from the incision site with or without fever
From time of delivery to time of hospital discharge; up to 6 weeks
Endometritis
Time Frame: From time of delivery to time of hospital discharge; up to 6 weeks
fundal tenderness and fever that required treatment with antibiotics
From time of delivery to time of hospital discharge; up to 6 weeks
5 minute Apgar Score less than 7 out of 10
Time Frame: 5 minutes following delivery; 5 minutes of neonatal life.
Neonatal Apgar scores consist of measurements of neonatal skin color, respiratory rate, heart rate, muscle tone, and irritability. Each parameter is given a score of 0, 1 or 2 based on standardized parameters. It is standard to perform this on all neonates at 1 minute and 5 minutes of life. Apgar scores are performed and calculated by nursing staff or members of the pediatric team. For this outcome, we are interested in scores less than 7 out of 10 at 5 minutes of life.
5 minutes following delivery; 5 minutes of neonatal life.
Neonatal intensive care unit admission
Time Frame: From time of delivery to hospital discharge; up to 6 weeks
Admission to the neonatal intensive care unit for greater than 24 hours
From time of delivery to hospital discharge; up to 6 weeks
Length of Labor
Time Frame: Time from placement of Foley catheter to time of delivery of neonate; up to 5 days
hours
Time from placement of Foley catheter to time of delivery of neonate; up to 5 days
Suspected or confirmed neonatal sepsis
Time Frame: From time of delivery to hospital discharge; up to 6 weeks
As clinical suspected by the neonatology team or with positive cultures
From time of delivery to hospital discharge; up to 6 weeks
Postpartum hemorrhage
Time Frame: From time of delivery to time of hospital discharge; up to 6 weeks
Delivery estimated blood loss of > 500 cc for vaginal delivery or > 1000 cc for cesarean delivery
From time of delivery to time of hospital discharge; up to 6 weeks
Delivery time less than 24 hours
Time Frame: From time of placement of Foley catheter to time of delivery of neonate; within 24 hours.
binary; yes/no
From time of placement of Foley catheter to time of delivery of neonate; within 24 hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily Miller, MD, Northwestern University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2017

Primary Completion (Actual)

December 1, 2022

Study Completion (Actual)

December 1, 2022

Study Registration Dates

First Submitted

December 15, 2016

First Submitted That Met QC Criteria

January 30, 2017

First Posted (Estimate)

February 1, 2017

Study Record Updates

Last Update Posted (Actual)

April 3, 2023

Last Update Submitted That Met QC Criteria

March 31, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Induction

Clinical Trials on Amniotomy

Subscribe